You are here: Industry Insights > antibody

News List

Neutralizing antibodies isolated from COVID-19 patients may suppress virus worldpharmanews
July 23, 2020
Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.
Celltrion begins Covid-19 human clinical trial with antiviral antibody treatment pharmaceutical-business-review
July 21, 2020
Celltrion Group has commenced phase 1 human clinical study to assess the potential of its antiviral antibody treatment for patients with Covid-19.
Phase III COVID-19 antibody trials initiated in Americas europeanpharmaceuticalreview
July 10, 2020
Simultaneous Phase III trials evaluating Regeneron’s REGN-COV2 antibody as both a prophylactic and a treatment have begun in US and some South American locations.
Busy Month of Approvals: A Review of Oncology Drugs Approved in May in China and world market PharmaSources/Xiaobin
July 03, 2020
The first half of 2020 will pass soon. Although foreign countries are still under the shadow of the COVID-19 pandemic, China’s situation is gradually stabilizing and improving through the concerted efforts of all to fight the pandemic.
Antibody levels in recovered COVID-19 patients decline quickly: research expresspharma
June 23, 2020
The research highlights the risks of using COVID-19 ‘immunity passports’ and supports the prolonged use of public health interventions such as social distancing and isolating high-risk groups, researchers said.
Researchers identify potent antibody cocktail to treat COVID-19 worldpharmanews
June 19, 2020
Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail and used as a promising anti-viral therapy against the virus that causes COVID-19.
Scientists discover new super-potent human antibodies that can protect against COVID-19 expresspharma
June 17, 2020
These antibodies may also be used to provide temporary, vaccine-like protection against SARS-CoV-2 infection for healthcare workers, elderly people, and others who respond poorly to traditional vaccines.
AstraZeneca licences Covid-19 antibody candidates from VU pharmaceutical-technology
June 10, 2020
AstraZeneca has licensed six coronavirus-neutralising antibody candidates from Vanderbilt University (VU) in the US, with plans to advance two into clinical development to prevent and treat Covid-19.
Just - Evotec Biologics, ABL Enter Clinical Supply Pact contractpharma
June 10, 2020
Just - Evotec Biologics to design a manufacturing process for the production of Phase I cGMP clinical supply of a broadly neutralizing antibody against HIV.
SwiftScale Manufactures COVID-19 Antibody Candidate contractpharma
June 10, 2020
Uses rapid biologics manufacturing technology to accelerate development of treatments.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page